corporary

IMAXIO

Active
SIREN 432792463 VAT number FR03432792463

Business purpose.

La propriété et l'exploitation , au sens des dispositions de l'article R 5124-2 du code de la Santé Publique, de spécialités pharmaceutiques et de tout autre produit de santé définis à l'article L 5121 -1 du code de la santé publique. Recherche et développement en biologie moléculaire, biochimie, chimie et en biotechnologie

IMAXIO is a company registered under SIREN number 432792463, with its registered office in PARIS. Its main activity falls under the sector: Scientific research and development. It has 4 establishments. 6 serving directors are recorded in the national business register. Its reported revenue for the financial year ended in 2023 is 0 euros.

Sources: INSEE Sirene, INPI RNE, INPI, annual accounts.

Identity

Legal form
SA with a board of directors (no further detail)
Activity
Research and experimental development on biotechnology (72.11Z)
Sector
Scientific research and development
Headcount
10 to 19 employees
Created
8 Sep 2000
Share capital
502,880.00 EUR
Registered with the trade register
13 Sep 2000
Financial year end
31/12
Establishments
4

Directors

Related companies

Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.

Other companies at the same address

8 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

38 / 100 D

Confidence: low · computed on the financial year ended 31 Dec 2023

Equity to assets (-68.7 %)
0.0 out of 30
EBITDA margin
data missing, component not taken into account
Liquidity (215.7 %)
9.9 out of 20
Debt (-204.7 %)
15.0 out of 15
Revenue trend
data missing, component not taken into account

formula fin-1.0

Legal score

80 / 100 A

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
20.0 out of 20
Age (26.2 years)
20.0 out of 20
Accounts filed recently
0.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Revenue and net income by financial year
2016 2017 2018 2022 2023

Revenue Net income

Financial year Revenue Change EBITDA Net income
31 Dec 2023 0 € — 0 € 134,239 €
31 Dec 2022 0 € — 0 € -94,914 €
31 Dec 2018 0 € -100.0 % 0 € 319,122 €
31 Dec 2017 2,458,536 € +6.3 % -29,022 € -757,348 €
31 Dec 2016 2,313,868 € first year on record -188,075 € -2,084,708 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Collective agreements

Agreements declared by the employer in its payroll filings.

  • Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.

    IDCC 0176 · repealed · 1 establishment · declared in July 2026

Legal notices

  • Filing of accounts 22 Dec 2024
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2023

    BODACC C n 20240247, annonce n 3610 · Proof of publication (PDF)

  • Filing of accounts 12 Mar 2024
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2022

    BODACC C n 20240050, annonce n 5667 · Proof of publication (PDF)

  • Filing of accounts 4 Nov 2022
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2021

    BODACC C n 20220215, annonce n 4643 · Proof of publication (PDF)

  • Filing of accounts 29 Apr 2022
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2020

    BODACC C n 20220084, annonce n 2427 · Proof of publication (PDF)

  • Filing of accounts 9 Mar 2021
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2019

    BODACC C n 20210047, annonce n 3983 · Proof of publication (PDF)

  • Filing of accounts 19 Dec 2019
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2018

    BODACC C n 20190244, annonce n 8330 · Proof of publication (PDF)

  • Filing of accounts 9 Apr 2019
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2017

    BODACC C n 20190070, annonce n 4576 · Proof of publication (PDF)

Public contracts won

29 current contracts

Source: essential public procurement data (DECP), Open Licence 2.0. Only the current version of each contract is shown.

Annual accounts as PDF →

Change history

  • officer_appointed (empty) → Administrateur 9 Oct 2026
  • officer_appointed (empty) → Commissaire aux comptes titulaire 9 Oct 2026
  • officer_appointed (empty) → Commissaire aux comptes suppleant 9 Oct 2026
  • officer_appointed (empty) → Autre 9 Oct 2026
  • officer_appointed (empty) → Administrateur 9 Oct 2026
  • officer_appointed (empty) → Directeur general delegue 9 Oct 2026

Frequently asked questions about IMAXIO

What is the SIREN number of IMAXIO?
The SIREN number of IMAXIO is 432792463. Its intra-community VAT number is FR03432792463.
Where is the head office of IMAXIO?
Head office address: 5 RUE SAINT-ROCH, 75001 PARIS.
When was IMAXIO founded?
IMAXIO was founded on 8 Sep 2000.
What does IMAXIO do?
Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
Who runs IMAXIO?
The officers listed in the register are ALEXANDRE Le Vert (Administrateur), PRADEYROL DEVELOPPEMENT (Administrateur), VALERIE MARIE CATHERINE Huertas (Directeur general delegue).
What is the revenue of IMAXIO?
The latest published revenue is 0 €, for the 2023 financial year.
How many employees does IMAXIO have?
The declared headcount is 10 to 19 employees. Insee data for 2024.
Is IMAXIO subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Show this profile on your website →

Report an error or request removal of this data